A second unit was established in 2010 in Auckland. In 2011 they formed Southern Clinical Trials Group (SCTG) to provide clinical governance, business development and administrative oversight to the trial sites. In 2019 there are 5 SCT sites (1 in Christchurch and 4 in Auckland). All sites are based in or around primary care and have access to large General Practice databases.
All SCT sites have experienced Principal Investigators and Study Coordinators. SCT sites have completed a wide range of phase 1B – 4 clinical trials. Recent trials include vaccine studies (influenza, hepatitis B, pneumococcal and HPV), lipid lowering, diabetes, osteoarthritis, immune response, migraine, soft tissue injuries, COPD, atopic dermatitis, asthma, rapid antigen devices, urticaria, aging, gout, endometriosis, cardiovascular outcomes, pain, depression and acute influenza.
SCT sites have on several occasions been highest study recruiters in the AsiaPac region. All SCT sites use a common CTMS and electronic source documents.
SCTG is part of the large Australian/New Zealand network Pacific Clinical Research Network. The head office is at Forte 2, 132 Peterborough St, Christchurch, New Zealand.
For more information: www.sctrials.co.nz